COVID19 STORIES
APPLY
Courses
Careers
GIVING
DIRECTORY
ALUMNI
LOGIN
Login to
Staff Portal
Login to
Learning Portal
Search
About CTeD
Meet the Team
Success Stories
Research Spotlights
Work with Us
Duke-NUS Researchers
Services
Available Technologies
Entrepreneurs
Useful Links
Industry
JointCTeD
Job Opportunities
FAQ
Our Ecosystem
Infrastructure and Support for Innovation
Start-up Landscape
Partner Organisations
Events
Contact Us
Available Technologies
Centre for Technology and Development
Work with Us
Available Technologies
Licensed Technologies
Nutrition
LPC - Formulations:
Vanteres
Education
Optimised Learning:
CognaLearn
Therapeutics
LPC - Diagnostics: Vanteres
LPC - Delivery Across BBB: Travecta Therapeutics
Anti-IL11 - Fibrosis:
Enleofen Bio
; then licensed to
Boehringer Ingelheim
5-HTP Formulations:
Evecxia Therapeutics
Mnk Inhibitors for Blood Cancers:
AUM Biosciences
Anti-Cancer Drug Candidate / Chemoprotection
: Under Option
CTL-Antigen Pairs for Cancer:
PairX Bio
Diagnostics
Surrogate Virus Neutralisation Test - cPass:
GenScript
Vaccines
Covid-19 Vaccine:
Arcturus Therapeutics
(co-development)
Available Technologies
for Licensing / Partnering
Therapeutics
HSPC Expansion
WARS2 Therapeutic Target
Development of Live Attenuated Viruses
Laminin: Keratinocytes for Burns
Laminin: Cardiac Progenitor Cells for Heart Diseases
WWP2 for Fibrosis
Treatment of Virus-Induced Thrombocytopenia
Preventing Foetal Transmission of Zika Virus
Inhibiting BK Channels for Treating Angelman Syndrome
HBV-Specific T Cells for Hepatocellular Carcinoma
Isoprenylcysteine Carboxyl Methyltransferase for Oncology
Bioinformatics
Integrating Spatial Transcriptomics Data with PRECAST
Ongoing CTeD Incubation Projects
Therapeutics
Mnk Inhibitors for Glioblastoma
Treatment of Vascular Pathology in Coronavirus Infection
Diagnostics
Wnt Companion Diagnostics
Prognosticating Effectiveness of JNK Inhibitors